Companies / Oncorus, Inc.
Oncorus, Inc.
ONCRCIK 1671818
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 17, 2021 | Flynn James E Director | Buy Open-market buy | Common Stock | $2.54M | +134K +10.53% | 1,401,905 | high |
| Feb 17, 2021 | Flynn James E Director | Buy Open-market buy | Common Stock | $2.54M | +134K +10.53% | 1,401,905 | high |
| Feb 17, 2021 | Flynn James E Director | Buy Open-market buy | Common Stock | $624.8K | +33K +10.53% | 345,167 | high |
| Apr 30, 2021 | Queva Christophe Executive | Sell Open-market sale | Common Stock | $362.7K | -23K -38.45% | 36,420 | medium |
| Apr 28, 2021 | Queva Christophe Executive | Sell Open-market sale | Common Stock | $273.8K | -18K -23.31% | 59,175 | medium |
| Jun 1, 2021 | Queva Christophe Executive | Sell Open-market sale | Common Stock | $215.3K | -13K -18.12% | 58,282 | medium |
| Jun 2, 2021 | Queva Christophe Executive | Sell Open-market sale | Common Stock | $177.5K | -11K -18.28% | 47,626 | medium |
| Nov 16, 2021 | Harbin Stephen Executive | Buy Open-market buy | Common Stock | $87.0K | +15K | 15,000 | medium |